GSK Sees Enduring Pricing Pressure Unlikely, Novo Projects Lower Growth In China, Lilly Bolsters Diabetes Presence In India: Emerging Markets Round Up (Part 1)

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.